Synapse - Craig Moskowitz

Search Within

Craig Moskowitz

Results (407)

Analysis of 121 allograft recipients for the treatment of lymphoma: Progressive disease by functional and/or CT imaging is a critical determinant of survival

Meeting Abstract

Sauter, C. S.; Moskowitz, C. H.; Barker, J. N.; Jakubowski, A. A.; Papadopoulos, E. B.; Perales, M. A.; Young, J. W.; Van Den Brink, M.; Zelenetz, A. D.; Castro-Malaspina, H. R.
Blood (2007)

Fulltext@MSK | Save

Rituximab maintenance following high dose therapy and autologous stem cell rescue after RICE cytoreduction improves event free and overall survival

Meeting Abstract

Rice, R. D.; Moskowitz, C. H.; Kewalramani, T.; Persky, D. O.; Rafferty, B. T.; Maragulia, J. C.; Zelenetz, A. D.
Blood (2007)

Fulltext@MSK | Save

A phase '2-1-2' study of two different doses and schedules of pralatrexate, a high affinity substrate for the reduced folate carrier (RFC-1), in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies

Meeting Abstract

O'Connor, O. A.; Hamlin, P.; Portlock, C.; Moskowitz, C.; Noy, A.; Straus, D.; Dumetrescu, O.; Sarasohn, D.; Neylon, E.; Hamelers, R.; more...
Molecular Cancer Therapeutics (2007)

Fulltext@MSK | Save

Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma

Meeting Abstract

Moskowitz, A.; Yahalom, J.; Kewalramani, T.; Tejerina, M.; Zelenetz, A. D.; Moskowitz, C. H.
Blood (2007)

Fulltext@MSK | Save

Late relapses characterize autologous transplantation (ASCT) in first complete remission (CR) for peripheral T-cell lymphoma (PTCL)

Meeting Abstract

Kewalramani, T.; Horwitz, S.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
Blood (2007)

Fulltext@MSK | Save

Relapsed and primary refractory diffuse large B-Cell lymphoma: Improving outcome by incorporating involved field radiotherapy into a comprehensive second-line high-dose therapy strategy

Meeting Abstract

Hoppe, B. S.; Yahalom, J.; Kewalramani, T.; Hamlin, P. A.; Rice, D.; Filippa, D.; Maragulia, J.; Weaver, A.; Moskowitz, C. H.
Blood (2007)

Fulltext@MSK | Save

Relapsed and primary refractory diffuse large cell lymphoma (DLCL) salvaged with involved field radiotherapy (IFRT) & high dose chemotherapy (HDCT) followed by autologous stem cell transplantation (ASCT)

Meeting Abstract

Hoppe, B. S.; Moskowitz, C. H.; Moskowitz, C. S.; Filippa, D. A.; Kewalramani, T.; Yahalom, J.
International Journal of Radiation Oncology, Biology, Physics (2007)

Fulltext@MSK | Save

Long-term outcome of survivors of autologous hematopoietic-cell transplantation for refractory and relapsed Hodgkin lymphoma

Meeting Abstract

Goodman, K. A.; Riedel, E.; Serrano, V.; Gonzales, A. M.; Gulati, S.; Moskowitz, C.; Yahalom, J.
Haematologica (2007)

Fulltext@MSK | Save

A non-Stanford mature experience with Stanford V +/- RT regimen for locally extensive and advanced Hodgkin's lymphoma (HL)

Meeting Abstract

Edwards-Bennett, S. M.; Moskowitz, C.; Jacobs, J.; Zelenetz, A.; Yahalom, J.
International Journal of Radiation Oncology, Biology, Physics (2007)

Fulltext@MSK | Save

Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma

Journal Article

O'Connor, O. A.; Hamlin, P. A.; Portlock, C.; Moskowitz, C. H.; Noy, A.; Straus, D. J.; Macgregor-Cortelli, B.; Neylon, E.; Sarasohn, D.; Dumetrescu, O.; more...
British Journal of Haematology (2007)

Fulltext@MSK | Save